Functional Analysis of Proposed Substrate-binding Residues of Hsp104

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Mar 11

PMID 32155221

Citations 3

Authors

Matthew K Howard

Brian S Sohn

Julius von Borcke

Andy Xu

Meredith E Jackrel

Affiliations

Soon will be listed here.

Abstract

Hsp104 is a hexameric AAA+ yeast disaggregase capable of solubilizing disordered aggregates and amyloid. Hsp104 couples ATP hydrolysis to polypeptide translocation through its central channel. Substrate binding by Hsp104 is mediated primarily by two conserved tyrosine residues in nucleotide binding domain (NBD) 1 and NBD2. Recent structural studies have revealed that an additional tyrosine residue (Y650) located in NBD2 appears to contact substrate and may play an important role in Hsp104 function. Here, we functionally analyze the properties of this proposed Hsp104 -substrate interaction. We find that Y650 is not essential for Hsp104 to confer thermotolerance. Supporting these findings, in a potentiated Hsp104 variant background, the Y650A mutation does not abolish potentiation. However, modulation of this site does have subtle effects on the activity of this potentiated Hsp104 variant. We therefore suggest that while Y650 is not essential for Hsp104 function, its modulation may be useful for fine-tuning Hsp104 properties.

Citing Articles

Hsp70 chaperones, Ssa1 and Ssa2, limit poly(A) binding protein aggregation.

Buchholz H, Martin S, Dorweiler J, Radtke C, Knier A, Beans N bioRxiv. 2025; .

PMID: 39896508 PMC: 11785122. DOI: 10.1101/2025.01.17.633617.

The middle domain of Hsp104 can ensure substrates are functional after processing.

Buchholz H, Dorweiler J, Guereca S, Wisniewski B, Shorter J, Manogaran A PLoS Genet. 2024; 20(10):e1011424.

PMID: 39361717 PMC: 11478891. DOI: 10.1371/journal.pgen.1011424.

Unique structural features govern the activity of a human mitochondrial AAA+ disaggregase, Skd3.

Cupo R, Rizo A, Braun G, Tse E, Chuang E, Gupta K Cell Rep. 2022; 40(13):111408.

PMID: 36170828 PMC: 9584538. DOI: 10.1016/j.celrep.2022.111408.

Drivers of Hsp104 potentiation revealed by scanning mutagenesis of the middle domain.

Ryan J, Bao A, Bell B, Ling C, Jackrel M Protein Sci. 2021; 30(8):1667-1685.

PMID: 34010483 PMC: 8284572. DOI: 10.1002/pro.4126.

References

Lum R, Niggemann M, Glover J . Peptide and protein binding in the axial channel of Hsp104. Insights into the mechanism of protein unfolding. J Biol Chem. 2008; 283(44):30139-50. PMC: 2662077. DOI: 10.1074/jbc.M804849200. View

Jackrel M, Shorter J . Engineering enhanced protein disaggregases for neurodegenerative disease. Prion. 2015; 9(2):90-109. PMC: 4601286. DOI: 10.1080/19336896.2015.1020277. View

Tariq A, Lin J, Jackrel M, Hesketh C, Carman P, Mack K . Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity. Cell Rep. 2019; 28(8):2080-2095.e6. PMC: 6750954. DOI: 10.1016/j.celrep.2019.07.069. View

Jackrel M, Shorter J . Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins. Dis Model Mech. 2014; 7(10):1175-84. PMC: 4174528. DOI: 10.1242/dmm.016113. View

Yasuda K, Clatterbuck-Soper S, Jackrel M, Shorter J, Mili S . FUS inclusions disrupt RNA localization by sequestering kinesin-1 and inhibiting microtubule detyrosination. J Cell Biol. 2017; 216(4):1015-1034. PMC: 5379945. DOI: 10.1083/jcb.201608022. View

Torrente M, Chuang E, Noll M, Jackrel M, Go M, Shorter J . Mechanistic Insights into Hsp104 Potentiation. J Biol Chem. 2016; 291(10):5101-15. PMC: 4777845. DOI: 10.1074/jbc.M115.707976. View

Jackrel M, Shorter J . Reversing deleterious protein aggregation with re-engineered protein disaggregases. Cell Cycle. 2014; 13(9):1379-83. PMC: 4050135. DOI: 10.4161/cc.28709. View

Jackrel M, DeSantis M, Martinez B, Castellano L, Stewart R, Caldwell K . Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell. 2014; 156(1-2):170-82. PMC: 3909490. DOI: 10.1016/j.cell.2013.11.047. View

Tessarz P, Mogk A, Bukau B . Substrate threading through the central pore of the Hsp104 chaperone as a common mechanism for protein disaggregation and prion propagation. Mol Microbiol. 2008; 68(1):87-97. DOI: 10.1111/j.1365-2958.2008.06135.x. View

10.

Sanchez Y, Lindquist S . HSP104 required for induced thermotolerance. Science. 1990; 248(4959):1112-5. DOI: 10.1126/science.2188365. View

11.

Parsell D, Kowal A, Singer M, Lindquist S . Protein disaggregation mediated by heat-shock protein Hsp104. Nature. 1994; 372(6505):475-8. DOI: 10.1038/372475a0. View

12.

Lee J, Sung N, Yeo L, Chang C, Lee S, Tsai F . Structural determinants for protein unfolding and translocation by the Hsp104 protein disaggregase. Biosci Rep. 2017; 37(6). PMC: 5741831. DOI: 10.1042/BSR20171399. View

13.

Gietz R, Schiestl R . High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protoc. 2007; 2(1):31-4. DOI: 10.1038/nprot.2007.13. View

14.

Newby G, Lindquist S . Blessings in disguise: biological benefits of prion-like mechanisms. Trends Cell Biol. 2013; 23(6):251-9. DOI: 10.1016/j.tcb.2013.01.007. View

15.

Chuang E, Hori A, Hesketh C, Shorter J . Amyloid assembly and disassembly. J Cell Sci. 2018; 131(8). PMC: 5963839. DOI: 10.1242/jcs.189928. View

16.

Jackrel M, Shorter J . Protein-Remodeling Factors As Potential Therapeutics for Neurodegenerative Disease. Front Neurosci. 2017; 11:99. PMC: 5328956. DOI: 10.3389/fnins.2017.00099. View

17.

Michalska K, Zhang K, March Z, Hatzos-Skintges C, Pintilie G, Bigelow L . Structure of Calcarisporiella thermophila Hsp104 Disaggregase that Antagonizes Diverse Proteotoxic Misfolding Events. Structure. 2019; 27(3):449-463.e7. PMC: 6403000. DOI: 10.1016/j.str.2018.11.001. View

18.

Yokom A, Gates S, Jackrel M, Mack K, Su M, Shorter J . Spiral architecture of the Hsp104 disaggregase reveals the basis for polypeptide translocation. Nat Struct Mol Biol. 2016; 23(9):830-7. PMC: 5509435. DOI: 10.1038/nsmb.3277. View

19.

Vacher C, Garcia-Oroz L, Rubinsztein D . Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease. Hum Mol Genet. 2005; 14(22):3425-33. DOI: 10.1093/hmg/ddi372. View

20.

Dobson C . Protein folding and misfolding. Nature. 2003; 426(6968):884-90. DOI: 10.1038/nature02261. View